Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent

Australian Veterinary Journal

Volumn 83, Issue 10, 2005, Pages 602-608

  Govendir, M ^a   Perkins, M ^a   Malik, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA; CANIS FAMILIARIS;

4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; BROMIDE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; PHENOBARBITAL; POTASSIUM BROMIDE; POTASSIUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; DRUG COMBINATION; ECONOMICS; EPILEPSY; FEMALE; MALE; PROSPECTIVE STUDY; SEIZURE; TREATMENT OUTCOME;

AMINES; ANIMALS; ANTICONVULSANTS; BROMIDES; CHEMOTHERAPY, ADJUVANT; CYCLOHEXANECARBOXYLIC ACIDS; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; MALE; PHENOBARBITAL; POTASSIUM COMPOUNDS; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 33644828150     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2005.tb13269.x     Document Type: Review

References (28)

1. Podell M, Fenner WR. Bromide therapy in refractory canine idiopathic epilepsy. J Vet Intern Med 1993;7:318-327.
2. Sachdeo R. Challenging our past paradigm in the management of epilepsy. Neurology 2000;55 (3 Suppl):S1-S4.
3. Booth DM. Anticonvulsant therapy in small animals. Vet Clin N Am Small Anim Pract 1998;28:411-447.
4. Podell M. Antiepileptic drug therapy. Clin Tech Small Anim Pract 1998;13:185-192.
5. Platt SR, Adams V, Garosi LS et al. Gabapentin as adjunctive therapy for refractory idiopathic epilepsy in dogs. 16th Annual European College of Veterinary Neurologists Symposium, Prague, 2003.
6. Knowles K. Idiopathic epilepsy. Clin Tech Small Anim Pract 1998;13:144-151.
7. Farnbach GC. Seizures in the dog. Part 1; Basis classification and predilection. J Am Anim Hosp Assoc 1984;24:421-424.
8. Fenner WR. Seizures. In: Kornegay JN, editor. Neurological Disorders. Contemporary Issues in Small Animal Practice. Churchill Livingston, New York, 1986;5:41-53.
9. Schwartz-Porsche D, Jurgens U. Wirksamkeit von Bromide bei den Therpieresistent epilesein de Hundes. Tierarzt Prax 1991;19:395-401.
10. March PA, Podell M, Sams RA. Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy beagles. J Vet Pharmacol Therap 2002;25:425-432.
11. Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a nonreferral-based population. J Am Vet Med Assoc 1995;206:1721-1728.
12. Dewey CW, Guiliano R, Boothe DM et al. Zonisamide therapy for refractory idiopathic epilepsy in dogs. J Am Anim Hosp Assoc 2004;40:285-291.
13. Müller PB, Wolfsheimer KL, Toboada J et al. Effects of long-term phenobarbitone treatment on the thyroid and adrenal axis and adrenal function tests in dogs J Vet Intern Med 2000;14:157-164.
14. Podell M. Strategies of antiepileptic drug therapy Proceedings of the American College of Veterinary Internal Medicine, Denver, CO 2001:430-431.
15. Taylor SM. Seizures. In: Nelson RW, Couto CG, editors. Small Animal Internal Medicine. 3rd edn. Mosby, St Louis, 2003: 991-1004.
16. Eiris J, Novo-Rodriguez MI, Del Rio M et al. The effects on lipid and apohpoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbitone therapy in children with epilepsy. Epilepsy Res 2000;41:1-7.
17. Farombi EO, Akinloye O, Akinmoladun CO et al. Hepatic drug metabolizing enzyme induction and serum tricyglycerol elevation in rats treated with chlordiazepoxide, griseofulvin, rifampicin and phenytoin. Clin Chim Acta 1999;289:1-10.
18. Goldberg DM, Yu A, Roomi MW et al. Effects of phenobarbitone upon triglycerol metabolism in the guinea pig. Can J Biochem 1981;59:48-53.
19. Foster SF, Church DB, Watson ADJ. Effects of phenobarbitone on serum biochemical tests in dogs. Aust Vet J 2000;78:23-26.
20. Derkx-Overduin LM. Slow-release phenytoin in canine epilepsy. [Thesis] Faculty of Veterinary Medicine, Utrecht, Netherlands: 1994.
21. Krebs-Breuer B. Hepatotoxicity of the anticonvulsant primidone in dogs. Clinical chemical and pathological findings during a long-term study. [Thesis] Fachbereich Veterinarmedizin. Freie Universitat, Berlin.Germany: 1995.
22. Ruehlmann D, Podell M, March P. Treatment of partial seizures and seizurelike activity with felbamate in six dogs. J Small Anim Pract 2001;42:403-408.
23. Palmer KJ. McTavish D. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drugs 1993; 45:1041-1065.
24. Willmore LJ. Clinical pharmacology of new antiepileptic drugs Neurology 2000;11: (3 Suppl) S17-S24.
25. Loscher W. Basic aspects of epilepsy. Curr Opin Neuro Neurosurg 1993;6:223-232.
26. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. J Am Med Assoc 2004;291.605-614.
27. Matar KM, Nicholls PJ, Bawazir SA et al. Effect of vigabatrin and gabapentin on phenytoin pharmacokinetics in the dog. Pharmacol Res 2000 42:6;517-521.
28. Radulovic LL, Turck D, von Hodenberg A et al. Disposition of gabapentin (Neurontin) in mice, rats, dogs and monkeys. Drug Metab Dispos 1995;24:441-448.